Skip to main content
. Author manuscript; available in PMC: 2010 Mar 25.
Published in final edited form as: Clin Cancer Res. 2009 Jan 1;15(1):131–139. doi: 10.1158/1078-0432.CCR-08-1691

Fig. 5.

Fig. 5

Histological examination (H&E) of PC-3 tumor xenograft sections after millirod implantation confirmed significant anti-tumor effects of β-lap in vivo. (A) Western analyses demonstrating NQO1 expression in explanted PC-3 xenografts. Cell lysate of parental LNCaP cells (NQO1−) was used as negative control. (B) A cross section of tumors treated with HPβ-CD-loaded millirod (4× magnification). Circled ‘R’ represents the millirod implantation site, while * indicates areas of patchy necrosis. (C) A cross section (4× magnification) of a tumor xenografts 6 days after implantation of β-lap-loaded millirods. (D) and (E) represent increased magnifications (40×) of (B) and (C), respectively.